MOAltria

$69.13
Altria logo

Price

$69.13+17%1Y
1M-4.1%1Y+17%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Top tier
9/10
Value55
Quality97
Momentum71
Growth48
Strongest Quality, weakest Growth · ranked vs Consumer Defensive peers. The five questions below judge the company on its own terms.
What they do

Our wholly owned subsidiaries include Philip Morris USA Inc. (“PM USA”), which is engaged in the manufacture and sale of cigarettes; John Middleton Co. (“Middleton”), which is engaged in the manufacture and sale of machine-made large cigars and is a wholly owned subsidiary of PM USA; UST LLC (“UST”), which, through its wholly owned subsidiary U.S. Smokeless Tobacco Company LLC (“USSTC”), is engaged in the manufacture and sale of moist smokeless tobacco (“MST”) products; Helix Innovations LLC (“Helix”) and its foreign affiliates (“Helix International”), which are engaged in the manufacture and sale of oral nicotine pouches; and NJOY, LLC (“NJOY”), which is engaged in the manufacture and sale of e-vapor products.

In the company’s own words · 10-K filed Feb 25, 2026 · SEC EDGAR

P/E (TTM)14.6
Market Cap$111.78B
1Y Return+17%
5Y Return+112%

Business segments

Q1 2026 · $5.43B

The company’s own SEC segment disclosure.

  • Smokeable Products$4.76B88%
  • Oral Tobacco$669.0M12%
  • All Other$1.0M0%

Altria (MO) reported revenue of $6.11B in Q2 2026 (quarter ended June 30, 2026), up 0.1% from the same quarter a year earlier. That came with a gross margin of 63% and net income of $2.30B (38% of revenue). For the full year FY2025, revenue was $23.3B (−3.1% year on year) and net income $6.95B. Its largest segment in 2026-Q1 was Smokeable Products at $4.76B, 88% of the disclosed total, just ahead of Oral Tobacco at 12%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.